However, interruptions of 6 or 12 months considerably influenced the tumor size (2).Our observations differed from the population study from Brazilian, wherein the HR negative or HER2 positive breast cancer, regarded as aggressive tumor subtypes, did not show higher percentage of patients with advanced-stage disease during the pandemic (16). This evidence concerns the gene ERBB2 and breast cancer.